The role of StAR-D3 in HER2 overexpressing breast cancer
<p>Background: HER2 overexpression in breast cancer is associated with poor prognosis. Trastuzumab is an anti-HER2 therapy and its clinical benefits have been established both in metastatic and early disease. However, Trastuzumab resistance is a common problem, even for patients who initially...
| Autore principale: | |
|---|---|
| Altri autori: | |
| Natura: | Tesi |
| Lingua: | English |
| Pubblicazione: |
2012
|
| Soggetti: |